National Health Investors, Inc. (NYSE:NHI) Receives $76.33 Average Target Price from Brokerages

National Health Investors, Inc. (NYSE:NHIGet Free Report) has received an average rating of “Moderate Buy” from the six brokerages that are presently covering the stock, Marketbeat reports. Two research analysts have rated the stock with a hold recommendation and four have assigned a buy recommendation to the company. The average twelve-month target price among brokerages that have covered the stock in the last year is $76.33.

A number of brokerages have recently weighed in on NHI. Wells Fargo & Company cut shares of National Health Investors from an “overweight” rating to an “equal weight” rating and boosted their price objective for the stock from $81.00 to $86.00 in a research note on Tuesday, October 1st. Bank of America started coverage on National Health Investors in a research report on Tuesday, September 24th. They issued a “buy” rating and a $92.00 price target on the stock. Truist Financial increased their price objective on National Health Investors from $65.00 to $78.00 and gave the company a “hold” rating in a research report on Friday, August 30th. Finally, StockNews.com lowered shares of National Health Investors from a “buy” rating to a “hold” rating in a research report on Tuesday, October 15th.

Get Our Latest Research Report on NHI

National Health Investors Price Performance

NYSE NHI opened at $72.76 on Friday. National Health Investors has a fifty-two week low of $51.59 and a fifty-two week high of $86.13. The stock’s 50-day moving average is $77.01 and its two-hundred day moving average is $75.53. The firm has a market cap of $3.30 billion, a P/E ratio of 25.00, a price-to-earnings-growth ratio of 4.87 and a beta of 1.04. The company has a debt-to-equity ratio of 0.92, a current ratio of 10.29 and a quick ratio of 10.29.

National Health Investors (NYSE:NHIGet Free Report) last issued its quarterly earnings data on Tuesday, November 5th. The real estate investment trust reported $0.65 earnings per share for the quarter, missing analysts’ consensus estimates of $1.07 by ($0.42). The company had revenue of $63.32 million during the quarter, compared to the consensus estimate of $67.93 million. National Health Investors had a net margin of 38.53% and a return on equity of 10.11%. The firm’s revenue was up 1.7% on a year-over-year basis. During the same period in the previous year, the business posted $1.08 earnings per share. On average, analysts anticipate that National Health Investors will post 4.42 earnings per share for the current fiscal year.

National Health Investors Dividend Announcement

The company also recently declared a quarterly dividend, which will be paid on Wednesday, January 29th. Investors of record on Tuesday, December 31st will be issued a dividend of $0.90 per share. This represents a $3.60 annualized dividend and a yield of 4.95%. The ex-dividend date of this dividend is Tuesday, December 31st. National Health Investors’s dividend payout ratio is currently 123.71%.

Institutional Trading of National Health Investors

Several hedge funds have recently modified their holdings of NHI. Quarry LP bought a new stake in shares of National Health Investors during the third quarter worth $27,000. Strategic Financial Concepts LLC bought a new stake in National Health Investors during the 2nd quarter worth about $28,000. Covestor Ltd grew its position in shares of National Health Investors by 2,700.0% during the 3rd quarter. Covestor Ltd now owns 420 shares of the real estate investment trust’s stock worth $35,000 after buying an additional 405 shares during the period. Point72 DIFC Ltd acquired a new stake in National Health Investors during the 3rd quarter worth $35,000. Finally, International Assets Investment Management LLC acquired a new stake in shares of National Health Investors during the second quarter worth $36,000. Institutional investors and hedge funds own 62.51% of the company’s stock.

About National Health Investors

(Get Free Report

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.

Further Reading

Analyst Recommendations for National Health Investors (NYSE:NHI)

Receive News & Ratings for National Health Investors Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for National Health Investors and related companies with MarketBeat.com's FREE daily email newsletter.